By Robin Carhart-Harris — 2020
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
Read on www.theguardian.com
CLEAR ALL
Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.
1
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
2
Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.
Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often-confusing relationship with psychoactive substances.
The Hopkins laboratory has also conducted a recent series of internet survey studies characterizing the effects hallucinogen-occasioned mystical experiences, challenging experiences, and effects on substance abuse.
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
Roland R. Griffiths, Ph.D. is a psychopharmacologist who serves as a professor and research coordinator at the Johns Hopkins University School of Medicine. This interview was captured during the Psychedemia conference at the University of Pennsylvania in September 2012.
In this edited version of Roland Griffith’s very information talk on Psilocybin (original title “The science of psilocybin and its use to relieve suffering”) we take a look at the amazing positive effects achieved with this controversial substance.